SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea · Delayed Price · Currency is KRW 824.00
+5.00 (0.61%)
At close: Jan 28, 2026
SCM Lifescience Revenue
SCM Lifescience had revenue of 638.80M KRW in the quarter ending June 30, 2025, with 139.55% growth. This brings the company's revenue in the last twelve months to 1.54B, up 53.75% year-over-year. In the year 2024, SCM Lifescience had annual revenue of 824.80M with 18.56% growth.
Revenue (ttm)
1.54B
Revenue Growth
+53.75%
P/S Ratio
23.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
36.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 824.80M | 129.10M | 18.56% |
| Dec 31, 2023 | 695.70M | 299.72M | 75.69% |
| Dec 31, 2022 | 395.98M | -43.28M | -9.85% |
| Dec 31, 2021 | 439.26M | 119.26M | 37.27% |
| Dec 31, 2020 | 320.01M | 151.51M | 89.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| J2KBIO | 31.12B |
| ADBiotech | 14.57B |
| Eutilex.Co.,Ltd | 10.54B |
| NGeneBio | 9.98B |
| MOA Life Plus | 9.80B |
| EyeGene | 4.10B |
| SunBio,Inc. | 2.17B |
| Aptamer Sciences | 1.08B |